NCT01994083

A Study of Multiple Oral Doses of IX-01 in Healthy Men

A Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of IX-01 in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Ixchelsis Limited · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the safety and tolerability of IX-01 after multiple doses, and to determine how the body handles IX-01.

Conditions

• Healthy Participants

Interventions

Type	Name	Description
DRUG	Placebo	Administered orally
DRUG	IX-01	Administered orally

Timeline

• Start date: 2013-11-01
• Primary completion: 2014-03-01
• Completion: 2014-03-01
• First posted: 2013-11-25
• Last updated: 2014-09-03

Locations

1 site across 1 country: United Kingdom